Editors' ChoiceCancer

Antiangiogenic cancer drug drives lymphangiogenic metastasis

See allHide authors and affiliations

Science Translational Medicine  08 Feb 2017:
Vol. 9, Issue 376, eaam6060
DOI: 10.1126/scitranslmed.aam6060


Tumor blood vessel–destroying cancer drug induces development of tumor lymphatics that contribute to treatment failure.

View Full Text

Stay Connected to Science Translational Medicine